Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 3
1989 1
1991 2
1992 3
1993 1
1994 8
1995 6
1996 6
1997 3
1998 5
1999 5
2000 9
2001 4
2002 8
2003 10
2004 7
2005 8
2006 3
2007 2
2008 3
2009 3
2010 5
2011 5
2012 9
2013 4
2014 6
2015 6
2016 9
2017 7
2018 6
2019 4
2020 4
2021 7
2022 5
2023 4
2024 9
2025 4
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
Scully M, Cataland SR, Peyvandi F, Coppo P, Knöbl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK; HERCULES Investigators. Scully M, et al. N Engl J Med. 2019 Jan 24;380(4):335-346. doi: 10.1056/NEJMoa1806311. Epub 2019 Jan 9. N Engl J Med. 2019. PMID: 30625070 Free article. Clinical Trial.
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura.
Scully M, Antun A, Cataland SR, Coppo P, Dossier C, Biebuyck N, Hassenpflug WA, Kentouche K, Knöbl P, Kremer Hovinga JA, López-Fernández MF, Matsumoto M, Ortel TL, Windyga J, Bhattacharya I, Cronin M, Li H, Mellgård B, Patel M, Patwari P, Xiao S, Zhang P, Wang LT; cTTP Phase 3 Study Investigators. Scully M, et al. N Engl J Med. 2024 May 2;390(17):1584-1596. doi: 10.1056/NEJMoa2314793. N Engl J Med. 2024. PMID: 38692292 Free article. Clinical Trial.
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).
Coppo P, Bubenheim M, Benhamou Y, Völker L, Brinkkötter P, Kühne L, Knöbl P, Mingot-Castellano ME, Pascual-Izquierdo C, de la Rubia J, Del Rio Garma J, Chaturvedi S, Masias C, Mazepa M, Zheng XL, Sinkovits G, Réti M, Patriquin CJ, Pavenski K, Boechat T, Farias J, Oliveira Ribeiro EF, Lobo de Andrade ML, Veyradier A, Joly B, Bouzid R, Sakai K, Matsumoto M, Agosti P, Mancini I, Peyvandi F, Gavriilaki E, Stubbs M, Hmaid A, Cataland S, Lämmle B, Scully M. Coppo P, et al. EClinicalMedicine. 2025 Mar 30;82:103168. doi: 10.1016/j.eclinm.2025.103168. eCollection 2025 Apr. EClinicalMedicine. 2025. PMID: 40235949 Free PMC article.
Thrombotic thrombocytopenic purpura.
Knöbl P. Knöbl P. Memo. 2018;11(3):220-226. doi: 10.1007/s12254-018-0429-6. Epub 2018 Aug 17. Memo. 2018. PMID: 30220931 Free PMC article. Review.
Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange.
Kühne L, Knöbl P, Eller K, Thaler J, Sperr WR, Gleixner K, Osterholt T, Kaufeld J, Menne J, Buxhofer-Ausch V, Mühlfeld A, Seelow E, Schreiber A, Todorova P, Cukoski S, Jabs WJ, Özcan F, Gäckler A, Schönfelder K, Seibert FS, Westhoff T, Schwenger V, Eichenauer DA, Völker LA, Brinkkoetter PT. Kühne L, et al. Blood. 2024 Oct 3;144(14):1486-1495. doi: 10.1182/blood.2023023780. Blood. 2024. PMID: 38838300 Free article.
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
Tiede A, Hart C, Knöbl P, Greil R, Oldenburg J, Sachs UJ, Miesbach W, Pfrepper C, Trautmann-Grill K, Holstein K, Pilch J, Möhnle P, Schindler C, Weigt C, Schipp D, May M, Dobbelstein C, Pelzer FJ, Werwitzke S, Klamroth R. Tiede A, et al. Lancet Haematol. 2023 Nov;10(11):e913-e921. doi: 10.1016/S2352-3026(23)00280-6. Epub 2023 Oct 16. Lancet Haematol. 2023. PMID: 37858328 Clinical Trial.
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D; TITAN Investigators. Peyvandi F, et al. N Engl J Med. 2016 Feb 11;374(6):511-22. doi: 10.1056/NEJMoa1505533. N Engl J Med. 2016. PMID: 26863353 Free article. Clinical Trial.
Acquired factor V inhibitors.
Knöbl P, Lechner K. Knöbl P, et al. Baillieres Clin Haematol. 1998 Jun;11(2):305-18. doi: 10.1016/s0950-3536(98)80050-4. Baillieres Clin Haematol. 1998. PMID: 10097809 Review.
185 results